The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price ...

Alarm** bells are ringing across Japan as startling new research reveals a staggering rise in heart failure incidents following COVID-19 vaccinations. Leading scientists from Japan's prestigious Keio ...

The U.S. government invests in cutting-edge mRNA technology to enhance pandemic preparedness and combat emerging infectious threats.

Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all COVID-19 vaccines in May 2021, just as vaccinated Americans ...

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...

New York Amsterdam News | Word In Black (WIB) - With the triad of respiratory viruses present in our day-to-day, it ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...